Development and external validation of a nomogram for individualized adjuvant imatinib duration for high‐risk gastrointestinal stromal tumors: A multicenter retrospective cohort study-Reference-Cited by-同舟云学术

Development and external validation of a nomogram for individualized adjuvant imatinib duration for high‐risk gastrointestinal stromal tumors: A multicenter retrospective cohort study

Published:2022-03-16 Issue:16 Volume:11 Page:3093-3105
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Medicine

Author:

Liu Ruolin¹,Wu Yingxin²,Gong Jin³,Zhao Rui⁴⁵,Li Li³,Wan Qianyi⁴,Lian Nan⁵,Shen Xiaoding⁴,Xia Lin⁴,Shen Yuhou⁴,Xiao Haitao¹,Wu Xiaoting⁴,Chen Yi⁴^ORCID,Cen Ying¹^ORCID,Xu Xuewen¹

Affiliation:

1. Department of Burn and Plastic Surgery West China Hospital of Sichuan University Chengdu China

2. Department of General Surgery, Center of Gastrointestinal and Minimally Invasive Surgery, The Third People's Hospital of Chengdu, Affiliated Hospital of Southwest Jiaotong University & The Second Affiliated Hospital of Chengdu Chongqing Medical University Chengdu China

3. Research and Education Department Sichuan Friendship Hospital Chengdu China

4. Department of Gastrointestinal Surgery West China Hospital of Sichuan University Chengdu China

5. Laboratory of Mitochondrial and Metabolism West China Hospital of Sichuan University Chengdu China

Funder

Key Research and Development Program of Sichuan Province

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.4673

Reference34 articles.